Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

2020-03-24 10:05

Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

BioResearch is following new recommendations for sponsors on how to manage the conduct of clinical trials in the context of the coronavirus disease (COVID-19) pandemic, published by The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA). Please click below link for details.

Go back

News

2020-10-01 09:29

We would like to inform you that we have completed the first part of the study with a single, escalating dose (FIH, SAD) (Part A), of the innovative antidiabetic drug.

The project was implemented in cooperation with a Polish pharmaceutical company.

2020-08-04 12:34

Dr Jarosław Długołęcki

We are pleased to welcome a new member of the BRG medical expert team. Mr Jarosław Długołęcki, (M.D.) - doctor with extensive knowledge and 16-years’ experience in clinical studies at the international level.

Read more … Dr Jarosław Długołęcki

2020-07-10 14:17

Badania kliniczne faz wczesnych szczepionek – wyzwania w obliczu nowych zagrożeń

Szczepienia ochronne niezaprzeczalnie należą do jednych z najbardziej przełomowych odkryć nowoczesnej medycyny.

2020-06-26 11:38

Publication in the Biotechnology magazine

We invite you to read our publication in the Biotechnology magazine - the largest industry portal in Poland, the latest information from the sectors: biotechnology, cosmetology, pharmacy and technologies.

2020-06-15 14:45

Promising antidiabetic drug

We have started an interesting study with a promising antidiabetic drug. The drug is designed in the form of prolonged-action tablets, which action leads to increased insulin secretion.

Read more … Promising antidiabetic drug

Page 5 of 10